nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM7—testis—testicular cancer	0.0267	0.044	CbGeAlD
L-Glutamine—TGM4—testis—testicular cancer	0.0153	0.0253	CbGeAlD
L-Glutamine—Glutathione—HPGDS—testicular cancer	0.0136	1	CrCbGaD
L-Glutamine—GLS—embryo—testicular cancer	0.013	0.0214	CbGeAlD
L-Glutamine—CCBL1—seminal vesicle—testicular cancer	0.013	0.0214	CbGeAlD
L-Glutamine—TGM2—embryo—testicular cancer	0.0129	0.0212	CbGeAlD
L-Glutamine—GFPT2—embryo—testicular cancer	0.0119	0.0196	CbGeAlD
L-Glutamine—CTPS1—seminal vesicle—testicular cancer	0.0114	0.0187	CbGeAlD
L-Glutamine—PFAS—seminal vesicle—testicular cancer	0.0112	0.0184	CbGeAlD
L-Glutamine—GFPT2—seminal vesicle—testicular cancer	0.0112	0.0184	CbGeAlD
L-Glutamine—QARS—embryo—testicular cancer	0.0102	0.0167	CbGeAlD
L-Glutamine—F13A1—seminal vesicle—testicular cancer	0.01	0.0165	CbGeAlD
L-Glutamine—TGM1—female gonad—testicular cancer	0.00969	0.016	CbGeAlD
L-Glutamine—QARS—seminal vesicle—testicular cancer	0.00954	0.0157	CbGeAlD
L-Glutamine—CAD—embryo—testicular cancer	0.00936	0.0154	CbGeAlD
L-Glutamine—GLS—gonad—testicular cancer	0.00884	0.0145	CbGeAlD
L-Glutamine—CAD—seminal vesicle—testicular cancer	0.0088	0.0145	CbGeAlD
L-Glutamine—TGM2—gonad—testicular cancer	0.00874	0.0144	CbGeAlD
L-Glutamine—TGM1—testis—testicular cancer	0.0086	0.0142	CbGeAlD
L-Glutamine—SLC38A3—testis—testicular cancer	0.0084	0.0138	CbGeAlD
L-Glutamine—NADSYN1—female gonad—testicular cancer	0.00831	0.0137	CbGeAlD
L-Glutamine—GLS2—female gonad—testicular cancer	0.00831	0.0137	CbGeAlD
L-Glutamine—CTPS1—gonad—testicular cancer	0.00823	0.0135	CbGeAlD
L-Glutamine—GMPS—gonad—testicular cancer	0.00823	0.0135	CbGeAlD
L-Glutamine—PPAT—seminal vesicle—testicular cancer	0.00816	0.0134	CbGeAlD
L-Glutamine—GFPT2—gonad—testicular cancer	0.00808	0.0133	CbGeAlD
L-Glutamine—PFAS—gonad—testicular cancer	0.00808	0.0133	CbGeAlD
L-Glutamine—TGM3—testis—testicular cancer	0.00806	0.0133	CbGeAlD
L-Glutamine—CCBL1—female gonad—testicular cancer	0.00762	0.0126	CbGeAlD
L-Glutamine—GATB—female gonad—testicular cancer	0.00762	0.0126	CbGeAlD
L-Glutamine—SLC1A5—seminal vesicle—testicular cancer	0.00755	0.0124	CbGeAlD
L-Glutamine—GLS2—testis—testicular cancer	0.00737	0.0121	CbGeAlD
L-Glutamine—NADSYN1—testis—testicular cancer	0.00737	0.0121	CbGeAlD
L-Glutamine—F13A1—gonad—testicular cancer	0.00725	0.0119	CbGeAlD
L-Glutamine—GLS—female gonad—testicular cancer	0.00718	0.0118	CbGeAlD
L-Glutamine—TGM2—female gonad—testicular cancer	0.0071	0.0117	CbGeAlD
L-Glutamine—QARS—gonad—testicular cancer	0.00689	0.0113	CbGeAlD
L-Glutamine—GATB—testis—testicular cancer	0.00676	0.0111	CbGeAlD
L-Glutamine—CCBL1—testis—testicular cancer	0.00676	0.0111	CbGeAlD
L-Glutamine—CTPS1—female gonad—testicular cancer	0.00669	0.011	CbGeAlD
L-Glutamine—GMPS—female gonad—testicular cancer	0.00669	0.011	CbGeAlD
L-Glutamine—PFAS—female gonad—testicular cancer	0.00657	0.0108	CbGeAlD
L-Glutamine—GFPT2—female gonad—testicular cancer	0.00657	0.0108	CbGeAlD
L-Glutamine—ASNS—seminal vesicle—testicular cancer	0.00648	0.0107	CbGeAlD
L-Glutamine—GLS—testis—testicular cancer	0.00637	0.0105	CbGeAlD
L-Glutamine—CAD—gonad—testicular cancer	0.00636	0.0105	CbGeAlD
L-Glutamine—TGM2—testis—testicular cancer	0.0063	0.0104	CbGeAlD
L-Glutamine—TGM1—lymph node—testicular cancer	0.00623	0.0103	CbGeAlD
L-Glutamine—CTPS1—testis—testicular cancer	0.00593	0.00977	CbGeAlD
L-Glutamine—GMPS—testis—testicular cancer	0.00593	0.00977	CbGeAlD
L-Glutamine—PPAT—gonad—testicular cancer	0.00589	0.00971	CbGeAlD
L-Glutamine—F13A1—female gonad—testicular cancer	0.00589	0.0097	CbGeAlD
L-Glutamine—GFPT2—testis—testicular cancer	0.00582	0.00959	CbGeAlD
L-Glutamine—PFAS—testis—testicular cancer	0.00582	0.00959	CbGeAlD
L-Glutamine—GLUL—embryo—testicular cancer	0.00563	0.00928	CbGeAlD
L-Glutamine—QARS—female gonad—testicular cancer	0.0056	0.00922	CbGeAlD
L-Glutamine—GLS2—lymph node—testicular cancer	0.00534	0.00879	CbGeAlD
L-Glutamine—NADSYN1—lymph node—testicular cancer	0.00534	0.00879	CbGeAlD
L-Glutamine—F13A1—testis—testicular cancer	0.00523	0.0086	CbGeAlD
L-Glutamine—CAD—female gonad—testicular cancer	0.00517	0.00851	CbGeAlD
L-Glutamine—QARS—testis—testicular cancer	0.00497	0.00818	CbGeAlD
L-Glutamine—SLC7A8—gonad—testicular cancer	0.00491	0.00809	CbGeAlD
L-Glutamine—CCBL1—lymph node—testicular cancer	0.0049	0.00807	CbGeAlD
L-Glutamine—GATB—lymph node—testicular cancer	0.0049	0.00807	CbGeAlD
L-Glutamine—PPAT—female gonad—testicular cancer	0.00479	0.00789	CbGeAlD
L-Glutamine—GLS—lymph node—testicular cancer	0.00462	0.0076	CbGeAlD
L-Glutamine—CAD—testis—testicular cancer	0.00458	0.00754	CbGeAlD
L-Glutamine—SLC1A5—female gonad—testicular cancer	0.00444	0.0073	CbGeAlD
L-Glutamine—CTPS1—lymph node—testicular cancer	0.0043	0.00708	CbGeAlD
L-Glutamine—GMPS—lymph node—testicular cancer	0.0043	0.00708	CbGeAlD
L-Glutamine—PPAT—testis—testicular cancer	0.00425	0.007	CbGeAlD
L-Glutamine—GFPT2—lymph node—testicular cancer	0.00422	0.00695	CbGeAlD
L-Glutamine—PFAS—lymph node—testicular cancer	0.00422	0.00695	CbGeAlD
L-Glutamine—SLC7A8—female gonad—testicular cancer	0.00399	0.00658	CbGeAlD
L-Glutamine—SLC1A5—testis—testicular cancer	0.00393	0.00648	CbGeAlD
L-Glutamine—GLUL—gonad—testicular cancer	0.00382	0.0063	CbGeAlD
L-Glutamine—ASNS—female gonad—testicular cancer	0.00381	0.00627	CbGeAlD
L-Glutamine—F13A1—lymph node—testicular cancer	0.00379	0.00624	CbGeAlD
L-Glutamine—QARS—lymph node—testicular cancer	0.0036	0.00593	CbGeAlD
L-Glutamine—SLC7A8—testis—testicular cancer	0.00354	0.00583	CbGeAlD
L-Glutamine—ASNS—testis—testicular cancer	0.00338	0.00556	CbGeAlD
L-Glutamine—CAD—lymph node—testicular cancer	0.00332	0.00547	CbGeAlD
L-Glutamine—GLUL—female gonad—testicular cancer	0.00311	0.00512	CbGeAlD
L-Glutamine—PPAT—lymph node—testicular cancer	0.00308	0.00507	CbGeAlD
L-Glutamine—SLC16A10—gonad—testicular cancer	0.00292	0.0048	CbGeAlD
L-Glutamine—SLC1A5—lymph node—testicular cancer	0.00285	0.0047	CbGeAlD
L-Glutamine—GLUL—testis—testicular cancer	0.00276	0.00454	CbGeAlD
L-Glutamine—SLC7A8—lymph node—testicular cancer	0.00257	0.00423	CbGeAlD
L-Glutamine—ASNS—lymph node—testicular cancer	0.00245	0.00403	CbGeAlD
L-Glutamine—SLC16A10—testis—testicular cancer	0.0021	0.00346	CbGeAlD
L-Glutamine—GLUL—lymph node—testicular cancer	0.002	0.00329	CbGeAlD
L-Glutamine—SLC16A10—lymph node—testicular cancer	0.00152	0.00251	CbGeAlD
L-Glutamine—Neuropathy peripheral—Etoposide—testicular cancer	0.00147	0.00388	CcSEcCtD
L-Glutamine—Discomfort—Bleomycin—testicular cancer	0.00146	0.00385	CcSEcCtD
L-Glutamine—Malaise—Dactinomycin—testicular cancer	0.00146	0.00385	CcSEcCtD
L-Glutamine—Urinary tract disorder—Cisplatin—testicular cancer	0.00145	0.00383	CcSEcCtD
L-Glutamine—Body temperature increased—Chlorambucil—testicular cancer	0.00145	0.00382	CcSEcCtD
L-Glutamine—Abdominal pain—Chlorambucil—testicular cancer	0.00145	0.00382	CcSEcCtD
L-Glutamine—Urethral disorder—Cisplatin—testicular cancer	0.00144	0.0038	CcSEcCtD
L-Glutamine—Constipation—Vinblastine—testicular cancer	0.00143	0.00379	CcSEcCtD
L-Glutamine—Pain—Vinblastine—testicular cancer	0.00143	0.00379	CcSEcCtD
L-Glutamine—Candida infection—Epirubicin—testicular cancer	0.00143	0.00379	CcSEcCtD
L-Glutamine—Oedema—Bleomycin—testicular cancer	0.00142	0.00374	CcSEcCtD
L-Glutamine—Infection—Bleomycin—testicular cancer	0.00141	0.00371	CcSEcCtD
L-Glutamine—Sepsis—Methotrexate—testicular cancer	0.00139	0.00368	CcSEcCtD
L-Glutamine—Feeling abnormal—Vinblastine—testicular cancer	0.00138	0.00365	CcSEcCtD
L-Glutamine—Injection site reaction—Doxorubicin—testicular cancer	0.00138	0.00365	CcSEcCtD
L-Glutamine—Myalgia—Dactinomycin—testicular cancer	0.00138	0.00364	CcSEcCtD
L-Glutamine—Ill-defined disorder—Ifosfamide—testicular cancer	0.00138	0.00363	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00137	0.00362	CcSEcCtD
L-Glutamine—Discomfort—Dactinomycin—testicular cancer	0.00136	0.00359	CcSEcCtD
L-Glutamine—Hypersensitivity—Chlorambucil—testicular cancer	0.00135	0.00356	CcSEcCtD
L-Glutamine—Malaise—Ifosfamide—testicular cancer	0.00134	0.00353	CcSEcCtD
L-Glutamine—Urinary tract disorder—Etoposide—testicular cancer	0.00133	0.00351	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—testicular cancer	0.00133	0.0035	CcSEcCtD
L-Glutamine—Abdominal pain—Vinblastine—testicular cancer	0.00133	0.0035	CcSEcCtD
L-Glutamine—Oedema—Dactinomycin—testicular cancer	0.00132	0.00349	CcSEcCtD
L-Glutamine—Urethral disorder—Etoposide—testicular cancer	0.00132	0.00348	CcSEcCtD
L-Glutamine—Asthenia—Chlorambucil—testicular cancer	0.00131	0.00347	CcSEcCtD
L-Glutamine—Infection—Dactinomycin—testicular cancer	0.00131	0.00346	CcSEcCtD
L-Glutamine—Sepsis—Epirubicin—testicular cancer	0.0013	0.00344	CcSEcCtD
L-Glutamine—Pruritus—Chlorambucil—testicular cancer	0.0013	0.00342	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00129	0.00341	CcSEcCtD
L-Glutamine—Malnutrition—Cisplatin—testicular cancer	0.00128	0.00338	CcSEcCtD
L-Glutamine—Arthralgia—Ifosfamide—testicular cancer	0.00126	0.00333	CcSEcCtD
L-Glutamine—Chest pain—Ifosfamide—testicular cancer	0.00126	0.00333	CcSEcCtD
L-Glutamine—Myalgia—Ifosfamide—testicular cancer	0.00126	0.00333	CcSEcCtD
L-Glutamine—Flatulence—Cisplatin—testicular cancer	0.00126	0.00333	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Epirubicin—testicular cancer	0.00125	0.00329	CcSEcCtD
L-Glutamine—Discomfort—Ifosfamide—testicular cancer	0.00125	0.00329	CcSEcCtD
L-Glutamine—Hypersensitivity—Vinblastine—testicular cancer	0.00124	0.00326	CcSEcCtD
L-Glutamine—Angiopathy—Etoposide—testicular cancer	0.00122	0.00322	CcSEcCtD
L-Glutamine—Pain—Bleomycin—testicular cancer	0.00121	0.0032	CcSEcCtD
L-Glutamine—Oedema—Ifosfamide—testicular cancer	0.00121	0.0032	CcSEcCtD
L-Glutamine—Chills—Etoposide—testicular cancer	0.00121	0.00319	CcSEcCtD
L-Glutamine—Sepsis—Doxorubicin—testicular cancer	0.00121	0.00318	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.0012	0.00318	CcSEcCtD
L-Glutamine—Asthenia—Vinblastine—testicular cancer	0.0012	0.00318	CcSEcCtD
L-Glutamine—Infection—Ifosfamide—testicular cancer	0.0012	0.00317	CcSEcCtD
L-Glutamine—Ill-defined disorder—Cisplatin—testicular cancer	0.00119	0.00313	CcSEcCtD
L-Glutamine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00117	0.00309	CcSEcCtD
L-Glutamine—Feeling abnormal—Bleomycin—testicular cancer	0.00117	0.00308	CcSEcCtD
L-Glutamine—Vomiting—Chlorambucil—testicular cancer	0.00116	0.00307	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00116	0.00305	CcSEcCtD
L-Glutamine—Malaise—Cisplatin—testicular cancer	0.00115	0.00304	CcSEcCtD
L-Glutamine—Fatigue—Dactinomycin—testicular cancer	0.00114	0.00301	CcSEcCtD
L-Glutamine—Back pain—Etoposide—testicular cancer	0.00113	0.00299	CcSEcCtD
L-Glutamine—Pain—Dactinomycin—testicular cancer	0.00113	0.00298	CcSEcCtD
L-Glutamine—Body temperature increased—Bleomycin—testicular cancer	0.00112	0.00296	CcSEcCtD
L-Glutamine—Dizziness—Vinblastine—testicular cancer	0.00111	0.00293	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.0011	0.00291	CcSEcCtD
L-Glutamine—Myalgia—Cisplatin—testicular cancer	0.00109	0.00287	CcSEcCtD
L-Glutamine—Feeling abnormal—Dactinomycin—testicular cancer	0.00109	0.00287	CcSEcCtD
L-Glutamine—Nausea—Chlorambucil—testicular cancer	0.00109	0.00287	CcSEcCtD
L-Glutamine—Ill-defined disorder—Etoposide—testicular cancer	0.00109	0.00287	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00108	0.00285	CcSEcCtD
L-Glutamine—Discomfort—Cisplatin—testicular cancer	0.00108	0.00284	CcSEcCtD
L-Glutamine—Vomiting—Vinblastine—testicular cancer	0.00107	0.00281	CcSEcCtD
L-Glutamine—Malaise—Etoposide—testicular cancer	0.00106	0.00279	CcSEcCtD
L-Glutamine—Headache—Vinblastine—testicular cancer	0.00105	0.00277	CcSEcCtD
L-Glutamine—Abdominal pain—Dactinomycin—testicular cancer	0.00104	0.00276	CcSEcCtD
L-Glutamine—Body temperature increased—Dactinomycin—testicular cancer	0.00104	0.00276	CcSEcCtD
L-Glutamine—Fatigue—Ifosfamide—testicular cancer	0.00104	0.00275	CcSEcCtD
L-Glutamine—Oedema—Cisplatin—testicular cancer	0.00104	0.00275	CcSEcCtD
L-Glutamine—Hypersensitivity—Bleomycin—testicular cancer	0.00104	0.00275	CcSEcCtD
L-Glutamine—Infection—Cisplatin—testicular cancer	0.00104	0.00274	CcSEcCtD
L-Glutamine—Constipation—Ifosfamide—testicular cancer	0.00104	0.00273	CcSEcCtD
L-Glutamine—Pain—Ifosfamide—testicular cancer	0.00104	0.00273	CcSEcCtD
L-Glutamine—Asthenia—Bleomycin—testicular cancer	0.00102	0.00268	CcSEcCtD
L-Glutamine—Dehydration—Epirubicin—testicular cancer	0.00101	0.00268	CcSEcCtD
L-Glutamine—Hyperhidrosis—Cisplatin—testicular cancer	0.00101	0.00266	CcSEcCtD
L-Glutamine—Pruritus—Bleomycin—testicular cancer	0.001	0.00265	CcSEcCtD
L-Glutamine—Feeling abnormal—Ifosfamide—testicular cancer	0.000998	0.00263	CcSEcCtD
L-Glutamine—Chest pain—Etoposide—testicular cancer	0.000998	0.00263	CcSEcCtD
L-Glutamine—Nausea—Vinblastine—testicular cancer	0.000997	0.00263	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00099	0.00261	CcSEcCtD
L-Glutamine—Pancreatitis—Methotrexate—testicular cancer	0.000988	0.00261	CcSEcCtD
L-Glutamine—Discomfort—Etoposide—testicular cancer	0.000986	0.0026	CcSEcCtD
L-Glutamine—Hypersensitivity—Dactinomycin—testicular cancer	0.000974	0.00257	CcSEcCtD
L-Glutamine—Body temperature increased—Ifosfamide—testicular cancer	0.000957	0.00253	CcSEcCtD
L-Glutamine—Abdominal pain—Ifosfamide—testicular cancer	0.000957	0.00253	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000951	0.00251	CcSEcCtD
L-Glutamine—Infection—Etoposide—testicular cancer	0.00095	0.00251	CcSEcCtD
L-Glutamine—Abdominal distension—Epirubicin—testicular cancer	0.000949	0.0025	CcSEcCtD
L-Glutamine—Asthenia—Dactinomycin—testicular cancer	0.000948	0.0025	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—testicular cancer	0.000939	0.00248	CcSEcCtD
L-Glutamine—Hyperhidrosis—Etoposide—testicular cancer	0.000925	0.00244	CcSEcCtD
L-Glutamine—Pancreatitis—Epirubicin—testicular cancer	0.000925	0.00244	CcSEcCtD
L-Glutamine—Vomiting—Bleomycin—testicular cancer	0.000901	0.00238	CcSEcCtD
L-Glutamine—Depression—Methotrexate—testicular cancer	0.000896	0.00236	CcSEcCtD
L-Glutamine—Rash—Bleomycin—testicular cancer	0.000894	0.00236	CcSEcCtD
L-Glutamine—Pain—Cisplatin—testicular cancer	0.000893	0.00236	CcSEcCtD
L-Glutamine—Dermatitis—Bleomycin—testicular cancer	0.000893	0.00236	CcSEcCtD
L-Glutamine—Hypersensitivity—Ifosfamide—testicular cancer	0.000892	0.00235	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—testicular cancer	0.000878	0.00232	CcSEcCtD
L-Glutamine—Asthenia—Ifosfamide—testicular cancer	0.000869	0.00229	CcSEcCtD
L-Glutamine—Feeling abnormal—Cisplatin—testicular cancer	0.00086	0.00227	CcSEcCtD
L-Glutamine—Pruritus—Ifosfamide—testicular cancer	0.000857	0.00226	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—testicular cancer	0.000855	0.00226	CcSEcCtD
L-Glutamine—Nausea—Bleomycin—testicular cancer	0.000842	0.00222	CcSEcCtD
L-Glutamine—Vomiting—Dactinomycin—testicular cancer	0.00084	0.00222	CcSEcCtD
L-Glutamine—Rash—Dactinomycin—testicular cancer	0.000833	0.0022	CcSEcCtD
L-Glutamine—Body temperature increased—Cisplatin—testicular cancer	0.000825	0.00218	CcSEcCtD
L-Glutamine—Fatigue—Etoposide—testicular cancer	0.000825	0.00218	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000824	0.00217	CcSEcCtD
L-Glutamine—Constipation—Etoposide—testicular cancer	0.000818	0.00216	CcSEcCtD
L-Glutamine—Pain—Etoposide—testicular cancer	0.000818	0.00216	CcSEcCtD
L-Glutamine—Dizziness—Ifosfamide—testicular cancer	0.000801	0.00211	CcSEcCtD
L-Glutamine—Pharyngitis—Methotrexate—testicular cancer	0.0008	0.00211	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—testicular cancer	0.000796	0.0021	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—testicular cancer	0.000791	0.00209	CcSEcCtD
L-Glutamine—Feeling abnormal—Etoposide—testicular cancer	0.000788	0.00208	CcSEcCtD
L-Glutamine—Nausea—Dactinomycin—testicular cancer	0.000785	0.00207	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—testicular cancer	0.000782	0.00206	CcSEcCtD
L-Glutamine—Vomiting—Ifosfamide—testicular cancer	0.00077	0.00203	CcSEcCtD
L-Glutamine—Hypersensitivity—Cisplatin—testicular cancer	0.000769	0.00203	CcSEcCtD
L-Glutamine—Rash—Ifosfamide—testicular cancer	0.000764	0.00201	CcSEcCtD
L-Glutamine—Dermatitis—Ifosfamide—testicular cancer	0.000763	0.00201	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000763	0.00201	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—testicular cancer	0.000757	0.002	CcSEcCtD
L-Glutamine—Abdominal pain—Etoposide—testicular cancer	0.000756	0.00199	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—testicular cancer	0.000756	0.00199	CcSEcCtD
L-Glutamine—Asthenia—Cisplatin—testicular cancer	0.000749	0.00198	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—testicular cancer	0.000749	0.00198	CcSEcCtD
L-Glutamine—Urinary tract disorder—Epirubicin—testicular cancer	0.000745	0.00197	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—testicular cancer	0.00074	0.00195	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—testicular cancer	0.000732	0.00193	CcSEcCtD
L-Glutamine—Chills—Methotrexate—testicular cancer	0.000724	0.00191	CcSEcCtD
L-Glutamine—Nausea—Ifosfamide—testicular cancer	0.000719	0.0019	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—testicular cancer	0.000707	0.00186	CcSEcCtD
L-Glutamine—Hypersensitivity—Etoposide—testicular cancer	0.000705	0.00186	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—testicular cancer	0.000702	0.00185	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—testicular cancer	0.0007	0.00185	CcSEcCtD
L-Glutamine—Pharyngitis—Doxorubicin—testicular cancer	0.000693	0.00183	CcSEcCtD
L-Glutamine—Urinary tract disorder—Doxorubicin—testicular cancer	0.00069	0.00182	CcSEcCtD
L-Glutamine—Asthenia—Etoposide—testicular cancer	0.000686	0.00181	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—testicular cancer	0.000685	0.00181	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—testicular cancer	0.000685	0.00181	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—testicular cancer	0.000679	0.00179	CcSEcCtD
L-Glutamine—Chills—Epirubicin—testicular cancer	0.000677	0.00179	CcSEcCtD
L-Glutamine—Pruritus—Etoposide—testicular cancer	0.000677	0.00179	CcSEcCtD
L-Glutamine—Vomiting—Cisplatin—testicular cancer	0.000664	0.00175	CcSEcCtD
L-Glutamine—Mental disorder—Epirubicin—testicular cancer	0.000661	0.00174	CcSEcCtD
L-Glutamine—Rash—Cisplatin—testicular cancer	0.000658	0.00174	CcSEcCtD
L-Glutamine—Dermatitis—Cisplatin—testicular cancer	0.000658	0.00174	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—testicular cancer	0.000657	0.00173	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—testicular cancer	0.000651	0.00172	CcSEcCtD
L-Glutamine—Flatulence—Epirubicin—testicular cancer	0.000647	0.00171	CcSEcCtD
L-Glutamine—Back pain—Epirubicin—testicular cancer	0.000636	0.00168	CcSEcCtD
L-Glutamine—Angiopathy—Doxorubicin—testicular cancer	0.000634	0.00167	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—testicular cancer	0.000633	0.00167	CcSEcCtD
L-Glutamine—Dizziness—Etoposide—testicular cancer	0.000633	0.00167	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—testicular cancer	0.000627	0.00165	CcSEcCtD
L-Glutamine—Nausea—Cisplatin—testicular cancer	0.00062	0.00164	CcSEcCtD
L-Glutamine—Mental disorder—Doxorubicin—testicular cancer	0.000612	0.00161	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—testicular cancer	0.00061	0.00161	CcSEcCtD
L-Glutamine—Vomiting—Etoposide—testicular cancer	0.000608	0.0016	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—testicular cancer	0.000608	0.0016	CcSEcCtD
L-Glutamine—Rash—Etoposide—testicular cancer	0.000603	0.00159	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—testicular cancer	0.000603	0.00159	CcSEcCtD
L-Glutamine—Headache—Etoposide—testicular cancer	0.000599	0.00158	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—testicular cancer	0.000599	0.00158	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—testicular cancer	0.000598	0.00158	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—testicular cancer	0.000598	0.00158	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—testicular cancer	0.000598	0.00158	CcSEcCtD
L-Glutamine—Malaise—Epirubicin—testicular cancer	0.000593	0.00156	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—testicular cancer	0.000591	0.00156	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—testicular cancer	0.000588	0.00155	CcSEcCtD
L-Glutamine—Infection—Methotrexate—testicular cancer	0.000569	0.0015	CcSEcCtD
L-Glutamine—Nausea—Etoposide—testicular cancer	0.000568	0.0015	CcSEcCtD
L-Glutamine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000564	0.00149	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—testicular cancer	0.000559	0.00148	CcSEcCtD
L-Glutamine—Chest pain—Epirubicin—testicular cancer	0.000559	0.00148	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—testicular cancer	0.000559	0.00148	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—testicular cancer	0.000554	0.00146	CcSEcCtD
L-Glutamine—Discomfort—Epirubicin—testicular cancer	0.000553	0.00146	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—testicular cancer	0.000548	0.00145	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—testicular cancer	0.000547	0.00144	CcSEcCtD
L-Glutamine—Oedema—Epirubicin—testicular cancer	0.000536	0.00141	CcSEcCtD
L-Glutamine—Infection—Epirubicin—testicular cancer	0.000533	0.00141	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000522	0.00138	CcSEcCtD
L-Glutamine—Hyperhidrosis—Epirubicin—testicular cancer	0.000518	0.00137	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—testicular cancer	0.000518	0.00137	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—testicular cancer	0.000518	0.00137	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—testicular cancer	0.000518	0.00137	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—testicular cancer	0.000518	0.00137	CcSEcCtD
L-Glutamine—Discomfort—Doxorubicin—testicular cancer	0.000511	0.00135	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—testicular cancer	0.000506	0.00134	CcSEcCtD
L-Glutamine—Oedema—Doxorubicin—testicular cancer	0.000496	0.00131	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—testicular cancer	0.000494	0.0013	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—testicular cancer	0.000493	0.0013	CcSEcCtD
L-Glutamine—Pain—Methotrexate—testicular cancer	0.00049	0.00129	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000489	0.00129	CcSEcCtD
L-Glutamine—Insomnia—Epirubicin—testicular cancer	0.000485	0.00128	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00048	0.00127	CcSEcCtD
L-Glutamine—Feeling abnormal—Methotrexate—testicular cancer	0.000472	0.00125	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000469	0.00124	CcSEcCtD
L-Glutamine—Fatigue—Epirubicin—testicular cancer	0.000462	0.00122	CcSEcCtD
L-Glutamine—Constipation—Epirubicin—testicular cancer	0.000459	0.00121	CcSEcCtD
L-Glutamine—Pain—Epirubicin—testicular cancer	0.000459	0.00121	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—testicular cancer	0.000453	0.00119	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—testicular cancer	0.000453	0.00119	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000452	0.00119	CcSEcCtD
L-Glutamine—Insomnia—Doxorubicin—testicular cancer	0.000449	0.00118	CcSEcCtD
L-Glutamine—Feeling abnormal—Epirubicin—testicular cancer	0.000442	0.00117	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000438	0.00116	CcSEcCtD
L-Glutamine—Fatigue—Doxorubicin—testicular cancer	0.000428	0.00113	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—testicular cancer	0.000424	0.00112	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—testicular cancer	0.000424	0.00112	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—testicular cancer	0.000424	0.00112	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—testicular cancer	0.000424	0.00112	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—testicular cancer	0.000422	0.00111	CcSEcCtD
L-Glutamine—Asthenia—Methotrexate—testicular cancer	0.000411	0.00108	CcSEcCtD
L-Glutamine—Feeling abnormal—Doxorubicin—testicular cancer	0.000409	0.00108	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000406	0.00107	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—testicular cancer	0.000405	0.00107	CcSEcCtD
L-Glutamine—Hypersensitivity—Epirubicin—testicular cancer	0.000395	0.00104	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—testicular cancer	0.000392	0.00103	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—testicular cancer	0.000392	0.00103	CcSEcCtD
L-Glutamine—Asthenia—Epirubicin—testicular cancer	0.000385	0.00101	CcSEcCtD
L-Glutamine—Pruritus—Epirubicin—testicular cancer	0.000379	0.001	CcSEcCtD
L-Glutamine—Dizziness—Methotrexate—testicular cancer	0.000379	0.001	CcSEcCtD
L-Glutamine—Hypersensitivity—Doxorubicin—testicular cancer	0.000366	0.000964	CcSEcCtD
L-Glutamine—Vomiting—Methotrexate—testicular cancer	0.000364	0.000961	CcSEcCtD
L-Glutamine—Rash—Methotrexate—testicular cancer	0.000361	0.000953	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—testicular cancer	0.000361	0.000952	CcSEcCtD
L-Glutamine—Headache—Methotrexate—testicular cancer	0.000359	0.000947	CcSEcCtD
L-Glutamine—Asthenia—Doxorubicin—testicular cancer	0.000356	0.000939	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—testicular cancer	0.000355	0.000935	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—testicular cancer	0.000351	0.000926	CcSEcCtD
L-Glutamine—Vomiting—Epirubicin—testicular cancer	0.000341	0.000899	CcSEcCtD
L-Glutamine—Nausea—Methotrexate—testicular cancer	0.00034	0.000898	CcSEcCtD
L-Glutamine—Rash—Epirubicin—testicular cancer	0.000338	0.000892	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—testicular cancer	0.000338	0.000891	CcSEcCtD
L-Glutamine—Headache—Epirubicin—testicular cancer	0.000336	0.000886	CcSEcCtD
L-Glutamine—Dizziness—Doxorubicin—testicular cancer	0.000328	0.000866	CcSEcCtD
L-Glutamine—Nausea—Epirubicin—testicular cancer	0.000319	0.00084	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—testicular cancer	0.000315	0.000832	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—testicular cancer	0.000313	0.000825	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—testicular cancer	0.000313	0.000825	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—testicular cancer	0.000311	0.00082	CcSEcCtD
L-Glutamine—Nausea—Doxorubicin—testicular cancer	0.000295	0.000777	CcSEcCtD
